Ecolab Launches Integrated Cooling Platform to Support AI Data Centers
ECL's new Cooling as a Service platform targets soaring AI data center demand with integrated site-to-chip efficiency upgrades.
HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience
HQY's new agentic AI is likely to provide faster, more intuitive support across channels, aiming to boost member satisfaction.
Boston Scientific Up 7% in a Month: How Should You Play the Stock?
BSX's month-long rally, strong Q3 beats and expansion into chronic pain solutions sharpen investor focus.
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.
STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics
Stereotaxis wins FDA clearance for GenesisX, a streamlined robotic system aimed at boosting hospital adoption and accelerating growth.
Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PODD's Q3 earnings and revenues top forecasts, with strong Omnipod growth and margin expansion lifting shares.
TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down
Teleflex posts strong Q3 earnings and revenue beats but trims 2025 outlook, sending shares slightly lower.
RGTI Stock Down Despite Q3 Earnings Top Estimates, Revenues Decline Y/Y
Rigetti's Q3 loss is narrower than estimates, but revenues decline as government contract delays hit sales and lower the gross margin.
Boston Scientific ( BSX ) Crossed Above the 200-Day Moving Average: What That Means for Investors
Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?
ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours
Alcon posts mixed Q3 results as earnings top estimates but revenues miss. new product launches fuel optimism.
J&J's MedTech Unit Sales Improve: Will the Momentum Last?
J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.
Cardiac Arrest Treatment Market Set for Remarkable Growth Driven by Advanced Emergency Care and Rising Cardiac Cases: Verified Market Research®
Lewes, Delaware, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Cardiac Arrest Treatment Market Size projected to grow at a CAGR of 4.50% from 2024 to 2031, according to a new report published by Verified Market Research®.
Brokers Suggest Investing in Boston Scientific ( BSX ) : Read This Before Placing a Bet
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PEN's Q3 results impress with double-digit sales growth, margin expansion and a strong 20% stock surge after its earnings beat.
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up
Veracyte surges 27.5% after Q3 earnings and revenues beat estimates, driven by strong Decipher and Afirma test growth.
Is Boston Scientific ( BSX ) a Solid Growth Stock? 3 Reasons to Think "Yes"
Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.
What's Behind Boston Scientific's Optimism for Urology Growth?
BSX sees stronger 2026 prospects for Urology, powered by Axonics integration, innovation and global Stone Management momentum.
AMN Stock Gains Following Q3 Earnings & Revenue Beat, Margins Down
AMN Healthcare beats third-quarter 2025 earnings and revenue estimates despite lower margins and year-over-year declines across key segments.
Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y
DOCS Q2 results benefit from the rise in AI-driven engagement. However, the stock plunges nearly 9% in pre-market trading.
Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
Boston, Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, "Patient Monitoring Devices: Global Markets" is projected to grow from $36.7 billion in 2025 to $55.8 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 8.7% during the forecast ...
A Look Into Boston Scientific Inc's Price Over Earnings - Boston Scientific ( NYSE:BSX )
In the current session, the stock is trading at $99.67, after a 0.62% increase. Over the past month, Boston Scientific Inc. ( NYSE:BSX ) stock increased by 3.82%, and in the past year, by 11.95%.
SOLV Gains on Q3 Earnings & Sales Beat, Raises '25 EPS Outlook
Solventum posts strong Q3 results with a revenue and earnings beat, lifts 2025 EPS guidance on solid MedSurg and HIS growth.
QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand
QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines.
Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y
INGN stock slid despite a narrower Q3 loss and rising B2B demand, as weaker consumer and rental sales weighed on results.
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y
PacBio posts a narrower Q3 loss and margin gains, but shares fall as revenues dip amid softer instrument demand.
CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract
CNMD beats third-quarter 2025 estimates on strength in surgery segments, but gross and operating margins see sharp contraction.
BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up
BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.
XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View
DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.
Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View
Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.
MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up
STERIS posts strong Q2 results with earnings and revenue beats, margin expansion, and a raised 2026 EPS outlook.
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop
Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.
Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract
HIMS reports lower third-quarter 2025 earnings even as revenue and subscriber growth remain strong across its channels.
MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand
Masimo beats third-quarter 2025 earnings and revenue estimates as operating margins and profits improve on lower expenses.
TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours
Tempus AI reports a narrower-than-expected Q3 loss and stronger revenues, raises full-year outlook, but shares decline following the results.
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View
Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment.
COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves
Cencora's Q4 results top estimates with 15% EPS growth and stronger margins, as GLP-1 demand and the RCA acquisition fuel solid segment gains.
FMS Stock Rises as Q3 Earnings Beat Estimates, Revenues Gain Y/Y
Fresenius Medical Care's Q3 earnings and revenues beat estimates, fueled by margin gains and solid organic growth across segments.
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
Bio-Techne's Q1 earnings meet expectations, but revenues slip 1%, sending shares lower despite stronger margins.
Is Anixa Biosciences ( ANIX ) Stock Outpacing Its Medical Peers This Year?
Here is how ANIXA BIOSCIENCES INC (ANIX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls
Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.
Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?
BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include The Chef's Warehouse, Life Time Group Holdings, The Honest Company, CorMedix and Boston Scientific.
INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised.
HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up
Henry Schein's Q3 earnings and revenues top estimates, lifting the stock as the company raised its 2025 outlook on solid business momentum.
HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands
Hologic posts solid Q4 gains with earnings and revenue beat, margin expansion, and a buyout deal by Blackstone and TPG.
Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand
MMSI beats third-quarter 2025 estimates on strong revenue and margin growth, prompting a raised full-year outlook across segments.
DexCom Stock Falls Despite Q3 Earnings Beat, 2025 Revenue View Raised
DXCM posts double-digit Q3 growth and raises 2025 revenue outlook, but shares tumble despite strong CGM momentum and innovation updates.
